3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
34
Squamous Cell Carcinoma of Head and Neck
22
Uterine Cervical Neoplasms
19
Lung Neoplasms
19
Small Cell Lung Carcinoma
16
Oropharyngeal Neoplasms
14
Ovarian Neoplasms
12
Carcinoma
10
Urinary Bladder Neoplasms
9
Stomach Neoplasms
9
Mouth Neoplasms
9
Laryngeal Neoplasms
9
Fallopian Tube Neoplasms
9
Hypopharyngeal Neoplasms
8
Mesothelioma, Malignant
7
Medulloblastoma
7
Cholangiocarcinoma
7
Breast Neoplasms
7
Adenocarcinoma of Lung
7
Pancreatic Neoplasms
6
Neuroblastoma
6
Nasopharyngeal Carcinoma
6
Gallbladder Neoplasms
6
Ganglioneuroblastoma
5
Brain Neoplasms
5
Triple Negative Breast Neoplasms
4
Prostatic Neoplasms
4
Lymphoid Interstitial Pneumonia
4
Head and Neck Neoplasms
4
Esophageal Neoplasms
4
Interventions
Doxorubicin
25
Radiotherapy
15
Ifosfamide
14
Trabectedin
10
pazopanib
6
ribociclib
5
pembrolizumab
5
Specimen Handling
5
Gemcitabine
5
Biopsy
5
palbociclib
4
Magnetic Resonance Spectroscopy
4
Docetaxel
4
Chemotherapy, Adjuvant
4
selinexor
3
liposomal doxorubicin
3
eribulin
3
X-Rays
3
Vincristine
3
Radiation
3
Neoadjuvant Therapy
3
Imatinib Mesylate
3
Filgrastim
3
Etoposide
3
Cyclophosphamide
3
toripalimab
2
temsirolimus
2
romidepsin
2
pegfilgrastim
2
cixutumumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Liposarcoma
×
Platinum
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled